Biodesix, Inc. - stock earnings
BDSX Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -9.1 million USD | 14.7 million USD |
| 2023Q3 | -10.9 million USD | 13.5 million USD |
| 2023Q2 | -13.4 million USD | 11.9 million USD |
| 2023Q1 | -17.1 million USD | 9.1 million USD |
| 2022Q4 | -26.8 million USD | 9.6 million USD |
| 2022Q3 | -16.8 million USD | 11.1 million USD |
| 2022Q2 | -20.0 million USD | 11.0 million USD |
| 2022Q1 | -16.8 million USD | 6.5 million USD |
| 2021Q4 | -13.3 million USD | 7.2 million USD |
| 2021Q3 | -11.5 million USD | 6.5 million USD |
| 2021Q2 | -11.4 million USD | 11.9 million USD |
| 2021Q1 | -7.0 million USD | 28.9 million USD |
| 2020Q4 | -4.5 million USD | 27.0 million USD |
| 2020Q3 | -8.8 million USD | 9.2 million USD |
| 2020Q2 | -8.3 million USD | 4.2 million USD |
| 2020Q1 | -9.7 million USD | 5.1 million USD |
| 2019Q4 | -6.5 million USD | 8.3 million USD |
| 2019Q3 | -9.6 million USD | 3.9 million USD |
| 2019Q2 | -7.7 million USD | 6.1 million USD |
| 2019Q1 | -7.7 million USD | 6.1 million USD |
| 2018Q4 | -7.7 million USD | 6.1 million USD |
| 2018Q2 | -6.5 million USD | 5.1 million USD |
| 2018Q1 | -6.5 million USD | 5.1 million USD |
| 2017Q4 | -6.5 million USD | 5.1 million USD |
BDSX Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -52.1 million USD | 49.1 million USD |
| 2022 | -80.4 million USD | 38.2 million USD |
| 2021 | -44.5 million USD | 54.5 million USD |
| 2020 | -36.5 million USD | 45.6 million USD |
| 2019 | -31.4 million USD | 24.6 million USD |
| 2018 | -26.2 million USD | 20.4 million USD |
BDSX
Price: $1.24
52 week price:
Earnings Per Share: -0.64 USD
P/E Ratio: -2.26
Exchange: NGM
Sector: Healthcare
Industry: Diagnostics & Research
Volume: 306900
Market Capitalization: 135.7 million